v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023   112,407      
Beginning balance at Dec. 31, 2023 $ 436,874 $ 112 $ 2,405,043 $ (1,962,575) $ (5,706)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (8,089)     (8,089)  
Other comprehensive income (loss), net of tax (3,007)       (3,007)
Issuance of common stock under stock option, award and purchase plans, net (in shares)   1,197      
Issuance of common stock under stock option, award and purchase plans, net (1,871) $ 1 (1,872)    
Repurchase of common stock (in shares)   (1,658)      
Repurchase of common stock (21,676) $ (1)   (21,675)  
Stock-based compensation 6,923   6,923    
Ending balance (in shares) at Mar. 29, 2024   111,946      
Ending balance at Mar. 29, 2024 $ 409,154 $ 112 2,410,094 (1,992,339) (8,713)
Beginning balance (in shares) at Dec. 31, 2024 116,735 116,735      
Beginning balance at Dec. 31, 2024 $ 465,258 $ 117 2,432,733 (1,953,495) (14,097)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 5,940     5,940  
Other comprehensive income (loss), net of tax 1,974       1,974
Issuance of common stock under stock option, award and purchase plans, net (in shares)   1,425      
Issuance of common stock under stock option, award and purchase plans, net $ 506 $ 1 505    
Repurchase of common stock (in shares) (3,500) (3,481)      
Repurchase of common stock $ (36,079) $ (3)   (36,076)  
Excise tax on share repurchases (241)     (241)  
Stock-based compensation $ 8,772   8,772    
Ending balance (in shares) at Mar. 28, 2025 114,679 114,679      
Ending balance at Mar. 28, 2025 $ 446,130 $ 115 $ 2,442,010 $ (1,983,872) $ (12,123)